Alzamend Neuro Inc. share price logo

Alzamend Neuro Inc.

NASDAQ: ALZN

Small Cap

$1.22

-0.03

(-2.40%)

as on

Alzamend Neuro Inc. Stock Performance

as on June 19, 2026 at 2:16 pm IST

  • Day's High

    $1.22
    $1.26

    3.28%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.84
    $3.60
    downward going graph

    31.15%

    Downside

    195.05%

    Upside

    downward going graph

Alzamend Neuro Inc. share price movements today

Previous Close
$1.25
Open
$1.25
Volume
310.6K
Day's Low - High
$1.22 - $1.26
52 Week Low - High
$0.84 - $3.60

Alzamend Neuro Inc. Historical Returns

1 Month Return
+ 20.79 %
3 Month Return
-35.45 %
1 Year Return
-59.6 %
3 Year Return
-99.87 %
5 Year Return
-99.99 %

Alzamend Neuro Inc. Stock Fundamentals & Key Indicators

Check Alzamend Neuro Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$4.8M

EPS (TTM)

-2.58

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-6.9M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-249.97%

Alzamend Neuro Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Alzamend Neuro Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Alzamend Neuro Inc. image
Alzamend Neuro Inc.
BUY$4.8M-99.99%NA0.00%NA
Alnylam Pharmaceuticals Inc. image
Alnylam Pharmaceuticals Inc.
BUY$37.7B57.21%71.2112.55%NA
Vertex Pharmaceuticals Inc. image
Vertex Pharmaceuticals Inc.
BUY$116.5B140.42%27.2235.51%NA
Regeneron Pharmaceuticals Inc. image
Regeneron Pharmaceuticals Inc.
BUY$63.7B13.39%14.8529.65%0.58%

Stock Returns calculator for Alzamend Neuro Inc. Stock including INR - Dollar returns

The Alzamend Neuro Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Alzamend Neuro Inc. investment value today

Current value as on today

₹43,872

Returns

-₹56,128

(-56.13%)

Returns from Alzamend Neuro Inc. Stock

-₹59,603 (-59.6%)

Dollar Impact

₹3,475 (+3.47%)

Analyst Recommendation on Alzamend Neuro Inc. Stock

Based on 8 analysts

BUY

75.00%

Buy

25.00%

Hold

0.00%

Sell

Based on 8 analysts, 75% of analysts recommend a 'BUY' rating for Alzamend Neuro Inc.. Average target price of $25

Alzamend Neuro Inc. Share Price Target

Get share price movements and forecasts by analysts on Alzamend Neuro Inc..

What analysts predicted

95.12%UPSIDE

Target Price

$25

Current Price

$1.22

Analyzed by

8 Analysts

Target

$25.00

Alzamend Neuro Inc. target price $25, a slight upside of 95.12% compared to current price of $1.22. According to 8 analysts rating.

Indian Investors' Interest in Alzamend Neuro Inc. Stock

Search interest for Alzamend Neuro Inc. Stock has decreased by -10% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-10% versus previous 30 day period

Alzamend Neuro Inc. Quarterly Profit & Loss

All numbers in Millions USD

Oct 2023
Jan 2024
Apr 2024
Jul 2024
Oct 2024
Jan 2025
Apr 2025
Jul 2025
Oct 2025
Jan 2026
Total Revenue
-
-
0
-
-
-
-
-
-
-
Gross Profit
0
0
0
0
0
0
0
0
0
0
Operating Income
-2
-2
0
0
-1
-1
-1
-2
0
-2
EBITDA
-2
-2
0
0
-1
-1
-1
-2
0
-2
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-2
-2
0
0
-1
-1
-1
-2
-1
-2
Income Tax Expense
-
0
0
-
-
-
-
-
-
-
Net Income
-2
-2
0
0
-1
-1
-1
-2
-1
-2
Net Profit Margin
0.00%
0.00%
-1118.81%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Alzamend Neuro Inc. Annual Profit & Loss

All numbers in Millions USD

Apr 2019
Apr 2020
Apr 2021
Apr 2022
Apr 2023
Apr 2024
Apr 2025
Total Revenue
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
0
0
0
Operating Income
-5
-4
-4
-12
-14
-9
-4
EBITDA
-5
-4
-4
-12
-14
-9
-4
Interest Expense
-
0
0
0
0
0
0
Depreciation
-
-
-
0
0
0
0
Income Before Tax
-4
-4
-5
-12
-14
-9
-4
Income Tax Expense
0
0
0
0
0
-
-
Net Income
-4
-4
-5
-12
-14
-9
-4
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Alzamend Neuro Inc. Quarterly Cash Flow

All numbers in Millions USD

Jan 2024
Apr 2024
Jul 2024
Oct 2024
Jan 2025
Apr 2025
Jul 2025
Oct 2025
Jan 2026
Net Income
-2
0
0
-1
0
-1
-2
-1
-2
Operating Cash Flow
-2
-1
-1
-3
-1
0
-2
-1
-1
Investing Cash Flow
-
0
0
-
-
0
-
-
-
Financing Cash Flow
2
1
1
6
0
1
4
-
-
Change in Cash
0
0
0
2
0
0
1
-1
-1

Alzamend Neuro Inc. Annual Cash Flow

All numbers in Millions USD

Apr 2017
Apr 2018
Apr 2019
Apr 2020
Apr 2021
Apr 2022
Apr 2023
Apr 2024
Apr 2025
Net Income
-1
0
-4
-4
-5
-12
-14
-9
-4
Operating Cash Flow
-1
-2
-1
-2
-2
-6
-8
-8
-6
Investing Cash Flow
0
0
0
0
0
0
-
0
0
Financing Cash Flow
1
2
0
2
4
18
0
3
10
Change in Cash
0
0
0
0
1
12
-8
-4
3

Global Institutional Holdings in Alzamend Neuro Inc.

Funds
Holdings
XTX Topco Ltd
0%
Activest Wealth Management
0%
Advisor Group Holdings, Inc.
0%
Morgan Stanley - Brokerage Accounts
0.47%
UBS Group AG
0.12%
See all

Insights on Alzamend Neuro Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Regeneron Pharmaceuticals, Inc. Common Stock has given 18.8% return, outperforming this stock by 78.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alzamend Neuro, Inc. Common Stock has experienced a drawdown of -99.9%, however Alnylam Pharmaceuticals, Inc. Common Stock resisted the overall trend and outperformed by 77.8%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, ALZN stock has moved down by -35.4%

About Alzamend Neuro Inc.

Alzamend Neuro, Inc., a clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. Its pipeline includes AL001, which delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer's, bi-polar disorder, post-traumatic stress disorder, major depressive disorder, other neurodegenerative diseases, and psychiatric disorders; and ALZN002, which uses a method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine to restore the ability of a patient's immunological system to combat Alzheimer's disease. Alzamend Neuro, Inc. was incorporated in 2016 and is headquartered in Atlanta, Georgia.
OrganisationAlzamend Neuro Inc.
Headquarters3480 Peachtree Road NE, Atlanta, GA, United States, 30326
IndustryBiotechnology
CEOMr. Stephan Jackman
E-voting on sharesClick here to vote

Key Management of Alzamend Neuro Inc.

Name

Title

Mr. Henry C. W. Nisser Esq.

Executive VP, General Counsel & Director

Mr. Kenneth S. Cragun CPA

Senior Vice President of Finance

Mr. Stephan Jackman

CEO & Director

Mr. Milton Charles Ault III

Founder & Vice Chairman

Mr. David J. Katzoff

Chief Financial Officer

FAQs

What is Alzamend Neuro Inc. share price today?

Alzamend Neuro Inc. share price today is $1.22 as on at the close of the market. Alzamend Neuro Inc. share today touched a day high of $1.26 and a low of $1.22.

What is the 52 week high and 52 week low for Alzamend Neuro Inc. share?

Alzamend Neuro Inc. share touched a 52 week high of $3.6 on and a 52 week low of $0.84 on . Alzamend Neuro Inc. stock price today i.e. is closed at $1.22,which is 66.11% down from its 52 week high and 45.24% up from its 52 week low.

What is Alzamend Neuro Inc.'s market capitalisation today?

Alzamend Neuro Inc. market capitalisation is $0.00T as on .

How to invest in Alzamend Neuro Inc. Stock (ALZN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Alzamend Neuro Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Alzamend Neuro Inc. Shares that will get you 1.2295 shares as per Alzamend Neuro Inc. share price of $1.22 per share as on June 19, 2026 at 8:46 am IST.

What is the minimum amount required to buy Alzamend Neuro Inc. Stock (ALZN) from India?

Indian investors can start investing in Alzamend Neuro Inc. (ALZN) shares with as little as ₹94.31 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹943.10 in Alzamend Neuro Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Alzamend Neuro Inc. share’s latest price of $1.22 as on June 19, 2026 at 8:46 am IST, you will get 8.1967 shares of Alzamend Neuro Inc.. Learn more about fractional shares .

What are the returns that Alzamend Neuro Inc. has given to Indian investors in the last 5 years?

Alzamend Neuro Inc. stock has given -99.99% share price returns and 27.56% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?